AMSTERDAM, BASEL, Switzerland and INGELHEIM, Germany, Jan. 9, 2025 /PRNewswire/ -- Boehringer Ingelheim and Synaffix B.V. ("Synaffix"), a Lonza company (SWX:LONN) focused on commercializing ...

Boehringer Ingelheim and Synaffix B.V. ("Synaffix"), a Lonza company (SWX:LONN) focused on commercializing its clinical-stage ...

After inking a series of partnerships late last year, Lonza’s antibody-drug conjugate (ADC) specialist Synaffix is kicking ...

Key Takeaways from the Cardiac Arrhythmia Monitoring Devices Market Report .On November 13, 2024, SmartCardia received FDA clearance for its Mobile Outpatient Cardiac Telemetry (OCT/MCT) system, which ...

On Janurary 7th, 2025, Annals of Oncology (IF: 56.7), a top oncology journal globally, published remarkable long-term ...

English teachers might have told students the word "each" is pronoun that gets a singular verb, but that's only part of the ...

PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery, today announced an expansion of their partnership with Pfizer. The parties will launch a new ...

Two anti-transferrin receptor (TfR) nanobodies, V H H123 specific for mouse TfR and V H H188 specific for human TfR (huTfR) were used to track transplants non-invasively by PET/CT in mouse models, ...

With new treatments in neurology, and more in development in cardiology and autoimmune diseases, precision medicine is moving ...

Geode Capital Management LLC grew its position in Pyxis Oncology, Inc. (NASDAQ:PYXS – Free Report) by 5.5% in the third ...

Brown’s little-known acquisition of Hitler’s personal library and the debate over what these books can or cannot reveal.